Evidence map›Paper›PMID 39554340›Full record

ReviewFood science & nutrition2024

Anticancer potential of Diospyrin and its analogues: An updated review.

Abdur Rauf, Zuneera Akram, Nabia Hafeez, Anees Ahmed Khalil, Ahood Khalid, Hassan A Hemeg, Abdullah S M Aljohani, Waleed Al Abdulmonem, Mohammed Mansour Quradha, Abdulkader Moqbel Farhan Qahtan

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Food science & nutrition, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Abdur RaufDepartment of Chemistry University of Swabi Anbar Khyber Pakhtunkhwa Pakistan.
Zuneera AkramDepartment of Pharmacology, Faculty of Pharmaceutical Sciences Baqai Medical University Karachi Pakistan.
Nabia HafeezCenter of Biotechnology and Microbiology University of Peshawar Peshawar Khyber Pakhtunkhwa Pakistan.
Anees Ahmed KhalilUniversity Institute of Diet and Nutritional Sciences, Faculty of Allied Health Sciences The University of Lahore Lahore Pakistan.ORCID https://orcid.org/0000-0003-3662-0933
Ahood KhalidUniversity Institute of Diet and Nutritional Sciences, Faculty of Allied Health Sciences The University of Lahore Lahore Pakistan.ORCID https://orcid.org/0000-0003-4674-9378
Hassan A HemegDepartment of Clinical Laboratory Sciences, College of Applied Medical Sciences Taibah University Al-Medinah Al-Monawara Saudi Arabia.
Abdullah S M AljohaniDepartment of Medical Biosciences, College of Veterinary Medicine Qassim University Buraydah Saudi Arabia.ORCID https://orcid.org/0000-0003-4017-7698
Waleed Al AbdulmonemDepartment of Pathology, College of Medicine Qassim University Buraydah Saudi Arabia.ORCID https://orcid.org/0000-0003-2984-9262
Mohammed Mansour QuradhaCollege of Education Seiyun University Seiyun Hadhramawt Yemen.ORCID https://orcid.org/0000-0002-8452-5343
Abdulkader Moqbel Farhan QahtanCollege of Education Seiyun University Seiyun Hadhramawt Yemen.ORCID https://orcid.org/0009-0009-8923-7867

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer, characterized as one of the leading causes of death owing to its heterogeneity and complexity, hence poses a significant challenge to health care system across the globe. Current therapies for cancer curtailment are considered to have associated side effects, therefore discovery of novel alternative approaches is need of the time. In this context, natural products have attained an essential spot in the scientific community for the development of novel cancer treatments. Among others, Diospyrin, a bis-hydroxy-naphthoquinonoid, is a vital bioactive component present in various

Indexed as

anticancerbioinformaticschemotherapyDiospyrinin vitropro‐apoptotic

Identifiers

PMID39554340
PMCPMC11561790

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.